Related Experiment Videos
Lymphocyte beta-adrenergic receptors are not altered in hyperthyroidism
Clinical Pharmacology and Therapeutics
|August 1, 1982
Summary
Thyrotoxicosis does not alter beta-adrenergic receptor density or binding affinity in lymphocytes. Studies found no changes in receptor number or binding strength in hyperthyroid patients compared to controls.
Area of Science:
- Endocrinology
- Pharmacology
- Cell Biology
Background:
- Thyrotoxicosis, a state of excess thyroid hormones, can affect various physiological systems.
- Beta-adrenergic receptors play a crucial role in mediating the effects of catecholamines.
Purpose of the Study:
- To investigate potential alterations in lymphocyte beta-adrenergic receptor number and binding affinity in patients with spontaneous hyperthyroidism.
- To compare receptor characteristics between thyrotoxic patients and healthy controls.
Main Methods:
- Lymphocytes were isolated from five thyrotoxic patients and five age- and sex-matched controls.
- Binding assays were performed using the radioligand (-)3H]-dihydroalprenolol (3H-DHA) to quantify beta-adrenergic receptor density and affinity.
Main Results:
- No significant differences were observed in beta-adrenergic receptor density between thyrotoxic patients and controls.
- Beta-adrenergic receptor binding affinity also remained unchanged in hyperthyroid individuals.
- Sequential analysis in one patient before and after becoming euthyroid showed no alteration in 3H-DHA binding.
Conclusions:
- Lymphocyte beta-adrenergic receptor density and affinity are not altered in spontaneous hyperthyroidism.
- These findings suggest that lymphocyte beta-adrenergic receptors may not be a primary site of dysregulation in this condition.